Skip to main content

Table 4 Conclusions generated according to different acceptance threshold ranges

From: Synthesizing evidence from clinical trials with dynamic interactive argument trees

Threshold range Overall Conclusion Safety Conclusion Efficacy Conclusion
[0,0.44] IGlar > NPH insuline IGlar > NPH insuline IGlar > NPH insuline
[0.45,0.70] IGlar > NPH insuline IGlar > NPH insuline IGlar NPH insuline
[0.71,1] IGlar NPH insuline IGlar > NPH insuline IGlar NPH insuline